Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Canadian Solar
CSIQ
$932M
| $4.3M | ﹤0.01% |
95,950
-45,646
| -32% | -$1.87M |
|
|
CARM
2002
DELISTED
Carisma Therapeutics
CARM
| $4.3M | ﹤0.01% |
46,555
+45,908
| +7,096% | +$2.93M |
|
|
MBT
2003
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $4.29M | ﹤0.01% |
463,441
+66,807
| +17% | +$594K |
|
2004
Healthcare Services Group
HCSG
$1.61B
| $4.29M | ﹤0.01% |
135,850
+1,473
| +1% | +$44.8K |
|
2005
ImmunityBio
IBRX
$7.15B
| $4.29M | ﹤0.01% |
300,113
+129,865
| +76% | +$2.15M |
|
2006
ProShares Russell 2000 Dividend Growers ETF
SMDV
$701M
| $4.29M | ﹤0.01% |
67,303
+5,523
| +9% | +$366K |
|
2007
PUT
Avis
CAR
$5.47B
| $4.28M | ﹤0.01% |
55,000
| – | – |
|
|
FLY
2008
DELISTED
Fly Leasing Limited
FLY
| $4.28M | ﹤0.01% |
+252,904
| New | +$4.28M |
|
|
DVAX
2009
DELISTED
Dynavax Technologies
DVAX
| $4.27M | ﹤0.01% |
433,929
+3,130
| +0.7% | +$28.5K |
|
|
GBIO
2010
DELISTED
Generation Bio
GBIO
| $4.27M | ﹤0.01% |
15,879
+3,844
| +32% | +$1.15M |
|
2011
Broadstone Net Lease
BNL
$4.25B
| $4.27M | ﹤0.01% |
182,407
+177,513
| +3,627% | +$3.81M |
|
|
DCPH
2012
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.27M | ﹤0.01% |
116,523
+16,655
| +17% | +$645K |
|
2013
Lumentum
LITE
$46.9B
| $4.26M | ﹤0.01% |
52,000
-36,466
| -41% | -$3.07M |
|
2014
Itron
ITRI
$4.54B
| $4.25M | ﹤0.01% |
42,544
+18,899
| +80% | +$1.75M |
|
2015
Insight Enterprises
NSIT
$3.85B
| $4.25M | ﹤0.01% |
42,484
+18,834
| +80% | +$1.9M |
|
2016
CALL
Nutrien
NTR
$33.9B
| $4.25M | ﹤0.01% |
70,000
| – | – |
|
|
SEM
2017
DELISTED
Select Medical
SEM
| $4.24M | ﹤0.01% |
186,315
+79,937
| +75% | +$1.66M |
|
|
TELL
2018
DELISTED
Tellurian Inc.
TELL
| $4.23M | ﹤0.01% |
910,263
+24,976
| +3% | +$76.6K |
|
2019
PUT
Iron Mountain
IRM
$35.9B
| $4.23M | ﹤0.01% |
100,000
| – | – |
|
2020
Acadia Pharmaceuticals
ACAD
$4.51B
| $4.23M | ﹤0.01% |
173,454
-21,313
| -11% | -$481K |
|
2021
Vodafone
VOD
$37.1B
| $4.23M | ﹤0.01% |
246,927
+56,978
| +30% | +$1.07M |
|
2022
Liberty Broadband Class A
LBRDA
$4.89B
| $4.23M | ﹤0.01% |
25,138
+7,133
| +40% | +$1.12M |
|
|
AIRC
2023
CALL
DELISTED
Apartment Income REIT Corp.
AIRC
| $4.22M | ﹤0.01% |
89,000
| – | – |
|
2024
Maximus
MMS
$3.32B
| $4.21M | ﹤0.01% |
47,802
+24,511
| +105% | +$2.25M |
|
|
SYNH
2025
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.2M | ﹤0.01% |
46,918
+20,114
| +75% | +$1.7M |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.